Vision
To establish novel, more effective method of precision care for patients who manifest psychosis and associated cognitive dysfunction in a wide range of medical conditions at the whole hospital levels.
Mission
Develop a new precision care for patients who manifest psychosis and associated cognitive dysfunction. A novel biomarker and medicine will be applied to these patients in a wide range of medical conditions, resulting in a mechanism-driven targeted approach with less side effects than traditional antipsychotics.
Research Aims for Precision Medicine
Novel drug discovery for psychosis that is not targeted by current antipsychotic medicines
Novel high-throughput biomarker for lysosome-originated psychosis
Right patients with this lysosome-originated mechanism for the right treatment
Patient Care
The psychosis PMCOE is closely linked to specialized consultation and on-going care for psychosis at Johns Hopkins Hospital and Johns Hopkins Bayview.